- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05501145
Clinical Features, Outcomes, and Therapeutics of Pregnancy-Related Aortic Dissection
September 25, 2022 updated by: Hong Liu, Nanjing Medical University
Clinical Features, Outcomes, and Therapeutics of Ppregnancy-related Aortic Dissection
Aortic dissection in pregnancy represents a lethal risk to both the mother and fetus, it has yet to yield the optimal therapeutic strategy.
The aim of this study was to characterize the clinical features and outcomes in women with pregnancy-related acute aortic dissection, and to suggest therapeutic guidelines.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
75
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China, 10029
- Beijing Anzhen Hospital
-
Guangzhou, China
- Department of Obstetrics and Gynecology, Guangdong Provincial People's Hospital
-
Qingdao, China
- Department of Cardiac Surgery, Affiliated Hospital of Qingdao University
-
Shanghai, China
- Department of Obstetrics and Gynecology, Zhongshan Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 43 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
From February 1 2012 through June 30 2022 for identification women who presented with aortic dissection during pregnancy or post partum ≤12 weeks
Description
Inclusion Criteria:
- Women who presented with aortic dissection during pregnancy or post partum ≤12 weeks.
Exclusion Criteria:
- Loss of surgical information.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
30-day mortality
Time Frame: 30 days after surgery
|
30 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Hong-jia Zhang, MD, Beijing Anzhen Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2022
Primary Completion (Actual)
July 31, 2022
Study Completion (Actual)
July 31, 2022
Study Registration Dates
First Submitted
August 12, 2022
First Submitted That Met QC Criteria
August 12, 2022
First Posted (Actual)
August 15, 2022
Study Record Updates
Last Update Posted (Actual)
September 27, 2022
Last Update Submitted That Met QC Criteria
September 25, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5A Plan VII
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Related
-
4YouandMeCambridge Cognition Ltd; Sema4; Evidation Health; Vector Institute of Artificial... and other collaboratorsCompletedPregnancy Related | Wearables | Pregnancy EarlyUnited States
-
Helen Keller InternationalEleanor Crook FoundationNot yet recruitingPregnancy Related | Supplementation | Postnatal Related
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Shaare Zedek Medical CenterUnknownPregnancy Related | Pregnancy, High Risk | Anesthesia
-
University of CopenhagenStanford UniversityNot yet recruiting
-
European Vaccine InitiativeKintampo Health Research Centre, Ghana; Groupe de Recherche Action en Sante; Fondation... and other collaboratorsRecruitingPregnancy RelatedBenin, Burkina Faso, Ghana, Malawi
-
Kahramanmaras Sutcu Imam UniversityNot yet recruitingPregnancy RelatedTurkey
-
Fondation Hôpital Saint-JosephRecruiting
-
German Institute of Human NutritionRecruiting
Clinical Trials on cesarean section and aortic repair
-
Saint Thomas Hospital, PanamaCompleted
-
Zeynep Kamil Maternity and Pediatric Research and...CompletedPain | Hemorrhage | Ileus | Postpartum FeverTurkey
-
Ain Shams UniversityUnknownNatural Cesarean Section
-
Bilge HospitalCompletedCesarean Section ComplicationsTurkey
-
Universidade do Vale do SapucaiCompleted
-
Mansoura UniversityCompletedPrevious Cesarean Section ScarEgypt
-
Aurora Health CareCompletedPatient Satisfaction | Earlier Family Bond Initiation | Maternal and Neonatal OutcomesUnited States
-
University of NebraskaWithdrawnCesarean Section
-
Beni-Suef UniversityActive, not recruitingCesarean Section | DehiscenceEgypt